Results
|
6161.
|
|
|
6162.
|
|
|
6163.
|
|
|
6164.
|
|
|
6165.
|
|
|
6166.
|
|
|
6167.
|
|
|
6168.
|
|
|
6169.
|
|
|
6170.
|
|
|
6171.
|
|
|
6172.
|
|
|
6173.
|
Indian Council of Medical Research. Task Force on Hormonal Contraception: Phase II randomized clinical trial with norethisterone oenanthate 50 mg alone and in combination with 5 mg or 2.5 mg of either estradiol valerate or cypionate as a monthly injectable contraceptive. [electronic resource] by
- Baweja, R
- Bhattacharya, S K
- Choudhury, S D
- Krishna, U
- Manuel, M
- Phillips, F S
- Datey, S
- Kumar, S
- Mehta, S
- Saxena, N C
Producer: 19860214
In:
Contraception vol. 32
Availability: No items available.
|
|
6174.
|
|
|
6175.
|
|
|
6176.
|
|
|
6177.
|
|
|
6178.
|
|
|
6179.
|
|
|
6180.
|
|